Glycocalyx damage negatively impacts the endothelium,
resulting endothelial dysfunction and an increased risk of cardiovascular
events. Sulodexide repairs the glycocalyx and reverses endothelial dysfunction,
protecting patients against cardiovascular events. Sulodexide has a low
incidence of adverse events and is well tolerated.